WHO Warns Of Aspergillus Fumigatus: Deadly Fungus With 85% Fatality, May Spread To 77% More Areas By 2100
Last Updated:
In 2022, WHO listed Aspergillus flavus as a critical fungal threat. As per a Daily Star report, it is drug-resistant and nearly incurable, posing serious health risks
A fresh wave of Covid-19 is once again sweeping across parts of the world, with a steady uptick in cases. Amid growing health concerns, the World Health Organization (WHO) has sounded an alarm over a new threat — a potentially more lethal fungal infection.
The fungus Aspergillus fumigatus, which causes the disease aspergillosis, primarily affects the lungs and, in severe cases, can spread to the brain. Health experts warn that the infection can prove fatal, especially in individuals with weakened immune systems.
Experts have warned that Aspergillus fumigatus could soon reach Britain, posing a significant threat to public health. The WHO has classified this fungus as a major public health concern, fearing its spread to North America, Europe, China and Russia.
The danger of Aspergillus fumigatus is underscored by its high mortality rate of 85.2% for invasive aspergillosis. In 2022, the WHO added Aspergillus flavus to its list of critical fungal pathogens. According to a report by the Daily Star, this fungus is not only a health threat but also resistant to drugs, making it nearly incurable.
A study by Manchester University, utilising a supercomputer, predicts that Aspergillus fumigatus could spread to 77% more areas by 2100, endangering millions. The fungus thrives in warm, moist environments such as compost heaps, decaying organic matter, and even the air, making it difficult to identify and treat.
Norman van Rijn, the lead author of the Manchester University study, noted that fungi have received less research attention compared to viruses and parasites. However, their maps indicate that fungal infections could become a global issue in the future.
First Published:
May 26, 2025, 16:52 IST
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
30 minutes ago
- Time of India
50 COVID-19 cases reported in Chhattisgarh, all mild, no cause for panic, says Health min
RAIPUR: Chhattisgarh has reported 50 confirmed cases of COVID-19 till Friday, but health authorities have urged citizens not to panic, assuring that all patients are exhibiting only mild, flu-like symptoms and do not require hospitalization. According to the State Health Department, symptoms such as low-grade fever, cold, cough, and sore throat have been observed in those infected. So far, 1,183 individuals have been tested, out of which 50 have tested positive with Covid-19. Of those positive, highest 31 patients were from Raipur and 12 from Bilaspur. Health Minister Shyam Bihari Jaiswal has directed all health officials across districts to ensure timely testing, contact tracing, and availability of sample collection services. Instructions have been given to refer only those with severe symptoms to hospitals for treatment. Minister Jaiswal has instructed Chief Medical and Health Officers (CMHOs), civil surgeons, and hospitals associated with medical colleges to maintain strict surveillance and testing protocols for suspected COVID-19 cases. Contact Tracing and Community Monitoring Underway Commissioner and Director of Health Services stated that rigorous surveillance is being carried out. Individuals who came into contact with infected patients are being identified and tested. Health teams have been dispatched to the respective localities for door-to-door surveys. 'Stay Alert, Not Afraid': Experts Advise Health experts from the Union Ministry of Health have stated that the currently circulating variant behaves similarly to seasonal flu, and there is no need for alarm. Chhattisgarh government has ensured all necessary preparations to handle both COVID-19 and seasonal illnesses. The public is being urged to remain cautious but calm. Get the latest lifestyle updates on Times of India, along with Eid wishes , messages , and quotes !
The Hindu
31 minutes ago
- The Hindu
Dedicated COVID-19 ward set up at Thoothukudi Government Medical College and Hospital
A dedicated 100-bed COVID-19 ward has been established at Thoothukudi Government Medical College and Hospital (TKGMCH) as a proactive step, despite no confirmed COVID cases in the district so far. The facility has been set up as a precautionary measure in line with state health directives. With COVID-19 cases emerging in several States across India, both the Central and State governments have ramped up preparedness to prevent further spread. As part of these efforts, the Director of Public Health and Preventive Medicine has issued detailed guidelines for the early identification of suspected cases across Primary Health Centres, District Head Quarters Hospital and Medical Colleges. District Microbiologists were instructed to facilitate proper collection of throat swab and nasal swab in Viral Transport Medium (VTM). Additionally, individuals with underlying health conditions, pregnant women, children and elderly were urged to wear face masks in public places as a preventive measure. In line with these precautionary protocols, a 100-bed special COVID-19 ward has been established at TKGMCH and is ready for use. Based on the guidelines of the Director of Public Health, all precautionary measures are being implemented in the hospital. Silas Jeyamani, Resident Medical Officer, confirmed that the hospital is well equipped with an adequate stock of liquid oxygen and essential medicines. He noted that the COVID-19 ward, which was actively used during the previous waves of pandemic, has now been prepared for potential use. He added that the government has instructed that patients exhibiting covid symptoms should undergo swab testing. If symptoms are detected, the patient will be isolated and their samples will be collected and sent to Chennai for testing. All necessary arrangements for the process have already been made at TKGMCH.
Time of India
an hour ago
- Time of India
Covid infections growing milder, occasional surges expected but don't worry: experts
New Delhi: Covid is growing milder with time but an occasional surge in cases is expected because the virus that causes it is now endemic and constantly evolving, say scientists while assuring that there is no cause for concern. Addressing worries over the rising incidence of the disease in various parts of the country, the experts noted that it appears to be a result of waning immunity combined with seasonal factors such as temperature extremes, which tend to keep us in air-conditioned spaces. They also stressed the need for caution, particularly in vulnerable sections of the population. "With every passing year, COVID-19 is causing milder infections. It is (now) just another respiratory illness and less dangerous than flu. We can forget COVID-19 as a special case. It is not a cause of concern," global health expert Dr Chandrakant Lahariya told PTI. "All the subvariants are similar, having a lower virulence but high infectivity. While highly susceptible people can still get severe disease, the vast majority don't, especially those who have had prior infections or vaccines," added Anurag Agarwal, dean of biosciences and health research, Trivedi school of biosciences at Ashoka University, Haryana. The World Health Organization declared an end to COVID-19 as a ' public health emergency' two years ago in May 2023. Health experts characterise the disease as 'seasonal', 'endemic', here to stay, or 'restricted to a certain region'. Active cases in the country crossed 5,300 as of June 6, with nearly 500 added in the past 24 hours. Of these, over 4,700 have recovered. The death toll is 55 in the current surge which started January this year, primarily among individuals with pre-existing illnesses, according to the Union Health ministry. "People with pre-existing illnesses and those older than 65 should follow standard precautions, as they would against any other respiratory infection -- not just for COVID-19," explained Lahariya, a consultant physician and former staff member of WHO. Kerala is the most affected with over 1,600 cases, followed by Gujarat, West Bengal, Delhi and Maharashtra, ministry data shows. The case surge in India is part of a wider wave impacting parts of Southeast Asia, including Singapore, Malaysia, Thailand and Hong Kong, which have been seeing a rise in infections over the past months. Wastewater surveillance by the Council of Scientific and Industrial Research-National Chemical Laboratory (NCL) has detected presence of SARS-CoV-2 -- which causes COVID-19 -- in samples from 10 sewage treatment plants in Pune, the Times of India reported. Patterns are similar to those seen in the weeks preceding earlier surges, NCL scientists were quoted as saying. Genome sequencing of samples from India's west and south have shown links to the subvariants of Omicron -- LF.7, XFG, JN.1 and NB.1.8.1. The cases are not severe and there is no need to worry, Director General of Indian Council of Medical Research (ICMR) Rajiv Behl said earlier this week. LF.7 and NB.1.8.1. have been classified as 'variants under monitoring' (VUM) by the WHO to alert public health authorities that a variant of SARS-CoV-2 requires prioritised attention and monitoring. JN.1 has been circulating in India since November 2023. The current situation, Behl stressed, is being monitored. Immunologist Satyajit Rath explained that the subvariants driving up case numbers indicate that they are probably better at binding themselves to human cells, despite pre-existing antibodies created in response to a prior infection or vaccination -- or 'infectivity'. "However, the important issue here is not their infectivity, but their tendency to cause severe disease, or 'virulence'," Rath, former scientist at New Delhi's National Institute of Immunology, told PTI. "Since selection pressure among the virus strains depends on infectivity and transmissibility -- and not on virulence -- there is no reason to expect a steady increase in the virulence of the emerging virus strains, which, in fact, has not at all been seen either," he added. Moreover, given that the COVID-19-causing virus is now endemic and constantly 'mutating' or evolving, ups and downs in infections in the population are expected, the health experts said. "People need not worry themselves until they are informed of a new 'variant of concern'. VUM is not relevant to the public, but only to public health authorities," Agarwal said. Lahariya advised the public to gather information from reliable sources and not to forward unverified messages, while Rath suggested that citizens keep a watch for the virulence of newly emerging strains. The experts also stressed on the role of authorities. "National and state governments in India should keep a watch on cases, monitor the trends in new cases and share data widely. The linkage between infections and clinical outcomes should be explored to understand the clinical features of the variants in circulation," Lahariya said. Rath drew attention to systemic issues that remain regarding preparedness of public health systems and availability of healthcare facilities across sections of the society should a virulent variant emerge. "The catch is, how efficiently, systematically and rigorously are our public health systems tracking virus strains, their infectivity and their virulence, not only for SARS-CoV-2 but for any other infection?" he asked. "Are we making next generation Covid vaccines at all? Are we making them available widely and affordably? Are we even carefully tracking evidence to see how well or poorly the current vaccine-induced immunity functions against emerging strains?" he added. The poor and vulnerable would need special protection "but are masks being made widely and freely available? "And if not, we are throwing poor communities onto their own resources even for taking such simple precautions, and that is a systemic problem," Rath said. PTI
